Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay–Sachs Disease
Authors:
- 1 March 2018
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 29 (3) , 312-326
Abstract
Tay–Sachs disease (TSD) is a fatal neurodegenerative disorder caused by a deficiency of the enzyme hexosaminidase A (HexA). TSD also occurs in sheep, the only experimental model of TSD that has clinical signs of disease. The natural history of sheep TSD was characterized using serial neurological evaluations, 7 Tesla magnetic resonance imaging, echocardiograms, electrodiagnostics, and cerebrospinal fluid biomarkers. Intracranial gene therapy was also tested using AAVrh8 monocistronic vectors encoding the α-subunit of Hex (TSD α) or a mixture of two vectors encoding both the α and β subunits separately (TSD α + β) injected at high (1.3 × 1013 vector genomes) or low (4.2 × 1012 vector genomes) dose. Delay of symptom onset and/or reduction of acquired symptoms were noted in all adeno-associated virus–treated sheep. Postmortem evaluation showed superior HexA and vector genome distribution in the brain of TSD α + β sheep compared to TSD α sheep, but spinal cord distribution was low in all groups. Isozyme analysis showed superior HexA formation after treatment with both vectors (TSD α + β), and ganglioside clearance was most widespread in the TSD α + β high-dose sheep. Microglial activation and proliferation in TSD sheep—most prominent in the cerebrum—were attenuated after gene therapy. This report demonstrates therapeutic efficacy for TSD in the sheep brain, which is on the same order of magnitude as a child's brain.Keywords
This publication has 42 references indexed in Scilit:
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapyJournal of Clinical Investigation, 2013
- Natural History of Infantile GM2 GangliosidosisPediatrics, 2011
- Serial MR Imaging and1H-MR Spectroscopy in Monozygotic Twins with Tay-Sachs DiseaseNeuropediatrics, 2008
- Serial 1H-MRS in GM2 gangliosidosesEuropean Journal of Pediatrics, 2007
- The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously ReportedPediatrics, 2006
- Effective gene therapy in an authentic model of Tay-Sachs-related diseasesProceedings of the National Academy of Sciences, 2006
- Reduced glutamate neurotransmission in patients with Alzheimer's disease?an in vivo 13C magnetic resonance spectroscopy studyMagnetic Resonance Materials in Physics, Biology and Medicine, 2003
- The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosisAnnals of Neurology, 1988
- Cardiac involvement in Sandhoff's diseaseThe American Journal of Cardiology, 1974
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957